Association of Interleukin 1 Family with Systemic Sclerosis

被引:0
作者
Li Zhang
Jun-Wei Yan
Yu-Jie Wang
Ya-Nan Wan
Bing-Xiang Wang
Jin-Hui Tao
Bing Chen
Bao-Zhu Li
Guo-Jun Yang
Jing Wang
机构
[1] Anhui Medical College,Medical Genetics Center
[2] Anhui Medical University,Department of Epidemiology and Biostatistics, School of Public Health
[3] Anhui Provincial Hospital Affiliated to Anhui Medical University,Department of Rheumatology and Immunology
[4] Anhui Medical University,School of Basic Medical Sciences
来源
Inflammation | 2014年 / 37卷
关键词
systemic sclerosis; SSc; interleukin 1 family; fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
Systemic sclerosis is a connective tissue disease characterized with fibrosis of skin and/or internal organs, and its specific pathological mechanism remains incompletely understood. IL-1 family, whose biological properties are typically pro-inflammatory and pro-fibrosis, has been associated with systemic sclerosis (SSc). Interleukin (IL)-1 family has 11 members, IL-1α, IL-1β, IL-1Ra, IL-18, IL-33, IL-36α, IL-36β, IL-36γ, IL-36Ra, IL-37, and IL-38. With the exception of IL-1Ra and IL-36Ra, each member has its own receptor signal. Abnormal expression of IL-1 and its potential role in the fibrosis process have been probed earliest, as well as its gene polymorphisms with SSc. IL-33 and IL-18 have also been discussed in the recent years, and IL-33 may contribute to the fibrosis of SSc, while IL-18 remains to be researched to confirm its role in fibrosis process. There is a lack of studies on the association of the other members of the IL-1 family, which might provide us the future study area; much more efforts need to be put on this matter.
引用
收藏
页码:1213 / 1220
页数:7
相关论文
共 150 条
[1]  
Wollheim FA(2005)Classification of systemic sclerosis. Visions and reality Rheumatology (Oxford) 44 1212-1216
[2]  
van den Hoogen F(2013)2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative Arthritis and Rheumatism 65 2737-2747
[3]  
Khanna D(2010)Epidemiology of systemic sclerosis Best Practice & Research. Clinical Rheumatology 24 857-869
[4]  
Fransen J(2013)New insights in the immunobiology of IL-1 family members Frontiers in Immunology 4 167-393
[5]  
Nikpour M(2013)Overview of the interleukin-1 family of ligands and receptors Semin Immunol 25 389-3005
[6]  
Stevens WM(2012)IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist Proceedings of the National Academy of Sciences of the United States of America 109 3001-672
[7]  
Herrick AL(1985)Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma Clinical and Experimental Immunology 59 666-89
[8]  
van de Veerdonk FL(1986)Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65 80-302
[9]  
Netea MG(1985)Interleukin-1 production by mononuclear cells from patients with scleroderma Clinical and Experimental Immunology 60 294-145
[10]  
Dinarello CA(1986)Studies of an interleukin 1 inhibitor: characterization and clinical significance Clinical and Experimental Immunology 64 136-319